Please assess the completion status of the following clinical trial:

Trial Title: Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: None
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven relapsed or refractory non-Hodgkin's lymphoma~* Scheduled to undergo high-dose chemotherapy (carmustine, etoposide, cytarabine, and melphalan) with autologous peripheral blood mononuclear cell transplantation~* No metastatic disease involving the bone marrow~PATIENT CHARACTERISTICS:~Age:~* 17 to 65~Performance status:~* ECOG 0 or 1~Life expectancy:~* Not specified~Hematopoietic:~* Absolute neutrophil count greater than 1,500/mm\^3~* Platelet count greater than 100,000/mm\^3~Hepatic:~* No active hepatitis B or C~* Bilirubin less than 2.5 times normal\*~* SGOT or SGPT less than 2.5 times normal\*~* Alkaline phosphatase less than 2.5 times normal NOTE: \* Unless Gilbert's syndrome present~Renal:~* Creatinine clearance greater than 50 mL/min~Cardiovascular:~* Cardiac ejection fraction normal~Pulmonary:~* DLCO at least 50% predicted~* FEV_1 and FVC at least 75% predicted~Other:~* HIV negative~* Not pregnant~* Negative pregnancy test~* No non-neoplastic disease that would preclude intensive chemotherapy~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* See Disease Characteristics~Chemotherapy:~* See Disease Characteristics~Endocrine therapy:~* Not specified~Radiotherapy:~* No prior external beam radiotherapy to more than 25% of the active bone marrow~Surgery:~* Not specified

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).